N-Acetylglucosaminyltransferase V (GnT-V) is one of the most relevant glycosyltransferases to tumor invasion and metastasis. Based on previous findings of molecular recognition between GnT-V and synthetic substrates, we designed and synthesized a p-iodophenyl-derivatized trisaccharide, 2-(4-
Introduction
The sugar chains of glycoproteins on cell surfaces, which are constructed by glycosyltransferases and glycosidases, change during particular biological events including development, carcinogenesis, and malignant transformation. Numerous studies conducted in the last two decades have demonstrated that N-acetylglucosaminyltransferase V (GnT-V) is relevant to tumor invasion and metastasis. Since Cummings first reported its expression in mouse lymphoma cells in 1982, 1 GnT-V has been shown to be highly expressed in various cancer cell lines and tissues from the early stages of tumorigenesis. [2] [3] [4] [5] [6] [7] [8] In addition, studies using GnT-V-deficient mice have directly demonstrated an essential role of GnT-V in tumor growth and metastasis. 9, 10 GnT-V catalyzes the transfer of an N-acetylglucosamine (GlcNAc) residue from a donor, UDP-GlcNAc, to an acceptor, the mannose α1-6 side chain of the trimannosyl core of N-glycans, to form a GlcNAcβ1-6Man linkage. This activity has been assessed predominantly using radiolabeled donors or fluorescent-labeled acceptors. In the former case, the production of sugar chains, the non-reducing ends of which are modified with radiolabeled GlcNAc by the enzymatic reaction, is measured through the use of a UDP-[ 3 H]GlcNAc or UDP-[ 14 C]GlcNAc donor. 2, 11, 12 However, there is a problem with specificity since UDP-GlcNAc functions as a substrate for many glycosyltransferases. In the latter case, a GnT-specific acceptor, GlcNAcβ1-2Manα1-3-(GlcNAcβ1-2Manα1-6)Manβ1-4GlcNAcβ1-4GlcNAc, is labeled with 2-aminopyridine to yield a fluorescent substrate (Gn,Gn-bi-PA). This acceptor is obtained from the carbohydrate moiety of human transferrin through laborious and time-consuming processes, repeated digestion with various enzymes, chemical modifications, and purification. [13] [14] [15] Moreover, the PA-oligosaccharide could still be a substrate of GnT-III.
Thus, we planned and produced a GnT-V-specific radioiodinated substrate for use in assays of GnT-V activity in vitro. First, to ensure a high degree of specificity, GlcNAcβ1-2Manα1-6Glc 12, [16] [17] [18] was employed as the saccharide moiety on the basis of previous findings; (i) it could not be a substrate of GnT-I and GnT-IV because of the lack of an acceptor site for GnT-I and GnT-IV, i.e., a Man residue linked to the bisecting Man with an α1-3 linkage, (ii) it is a poor substrate of GnT-III because of the replacement of the acceptor residue, i.e., bisecting Man, with Glc, and (iii) it already carries an GlcNAc residue that should be transferred by GnT-II. Second, the 1-hydroxyl of the reducing terminal Glc, which was adopted as a substitute of the bisecting Man, was conjugated with a hydrophobic phenethyl group without loss of activity. 11, 12, [16] [17] [18] Finally, the radioiodine 125 I was considered to be incorporated into the para-position of the phenyl ring immediately before the biological assay because the parasubstitution of iodine is effective in preventing deiodination in vivo. 19 The p-iodophenyl-derivatized to afford disaccharide 7 (57%). Subsequent treatment of 7 with hydrazine hydrate followed by acetylation yielded 8 (80%, two steps). Debenzylidenation of 8 in 70% AcOH and subsequent acetylation yielded intermediate 9 (80%, two steps), whose hydrogenolysis and acetylation afforded octaacetate 10 (86%, two steps). Subsequent treatment of 10 with 30% HBr-AcOH afforded 3, which was used as the glycosyl donor for the next reaction (Scheme 2 It was anticipated that no-carrier-added preparation would result in a final product bearing a theoretical specific activity similar to that of 125 I. The radiochemical identity of [ 125 I]1 was verified by co-injection with nonradioactive 1 and comparison of their HPLC profiles. The final radioiodinated compound [ 125 I]1 showed a single peak of radioactivity at the same retention time as that of nonradioactive 1. The radioiodinated product was obtained in 50% radiochemical yield with a radiochemical purity of > 95% after HPLC. 2) , the N-acetylglucosaminylated product of 1, was synthesized starting with removal of the benzyliden group of 7 with 70% AcOH to afford 23 (83%).
Selective silylation of 6-OH of the mannose unit with tert-butyldimethylsilyl chloride yielded 24 (94%), the remaining hydroxyl group of which was acetylated to afford 25 (99%). Treatment of 25 with pyridinium p-toluenesulfonate afforded 26 (75%), whose glycosylation with the bromide 6 promoted by silver trifluoromethanesulfonate and collidine yielded 27 (40%). Removal of the N-phthalimido groups with hydrazine hydrate and subsequent acetylation yielded 28 (93%, two steps). Cleavage of the benzyl groups of 28 by hydrogenolysis followed by acetylation yielded 29 (72%, two steps). Treatment of 29 in acetic anhydride with HBr yielded bromide 30. Glycosylation of 4 with bromide 30 promoted by silver carbonate and silver perchlorate yielded 31 (7%, two steps), which was sequentially deacetylated to furnish the target compound 2 (Scheme 5).
Biological Studies.
A typical HPLC profile of the GnT-V-reaction products of [ 125 I]1 is shown in Figure 2 . The reaction products showed peaks at retention times of 21 and 30 min, respectively, identical to those of the nonradioactive compounds 2 and 1.
This result indicates that GnT-V catalyzes the transfer of a GlcNAc residue from UDP-GlcNAc to [ 125 I]1 to form a β1-6 linkage, providing evidence that [ 125 I]1 acts as a substrate for GnT-V.
The kinetics of the conversion of 1 to 2 by GnT-V were determined using the IPGMG solution containing [ 125 I]1. This radioiodinated substrate exhibited saturation kinetics at high substrate concentrations ( Figure 3A ). The data satisfied the Michaelis-Menten equation, originally developed for enzymatic kinetics. The kinetic parameters were K m = 23.7 µM and V max = 159 pmol/h·µg protein, determined from the double-reciprocal Lineweaver-Burk plot ( Figure 3B ). The K m value is one order of magnitude lower than that for a fluorescent substrate, Gn,Gn-bi-PA.
The novel radioiodinated substrate [ 125 I]1 was used to assay GnT-V activity in crude extracts of various tissues in normal rats. To compare the findings with previous results obtained using Gn,Gn-bi-PA as a substrate, we assayed the GnT-V activity under similar experimental conditions. 13 The results are summarized in Table 1 . This enzyme was uniformly distributed in rat tissues with relatively high activity levels in the small intestine and serum. A similar tendency was observed in a previous investigation using Gn,Gn-bi-PA. 13 The reaction velocity using [ 125 I]1 was 3-to 22-fold greater than that using Gn,Gn-bi-PA. These findings demonstrate that 1 serves as a better substrate for GnT-V than Gn,Gn-bi-PA.
Conclusions
We successfully designed and synthesized a novel radioiodinated trisaccharide derivative, [ 125 I]1, as a synthetic substrate for GnT-V. [ 125 I]1 exhibited higher affinity than a fluorescent substrate, Gn,Gn-bi-PA, suggesting it to be the preferred acceptor for this enzyme. The present findings contribute to the development of sensitive in vitro GnT-V assays.
Experimental Sections

Synthetic Methods
All reagents were commercial products and used without further purification unless otherwise indicated. 1 H-NMR spectra were obtained on a JEOL JNM EX-270, JNM AL-300, and Varian Unity INOVA 400 spectrometer. Signals are given in ppm using tetramethylsilane as an internal standard. MS spectra were determined on a JEOL JMX-SX102A QQ and Shimadzu LCMS-QP8000α mass spectrometer.
Benzyl 3-O-benzyl-4,6-O-benzylidiene-2-O-[3,4,6-tri-O-acetyl-2-deoxy-2-phthalimido-ß-Dglucopyranosyl]-α-D-mannopyranoside (7).
To a mixture of 5 (255 mg, 0.57 mmol), silver trifluoromethanesulfonate (263 mg, 1.02 mmol), and collidine (135 µL, 1.02 mmol) in nitromethane (1 mL) was added a nitromethane (2 mL) solution of 6 (426 mg, 0.86 mmol) at -20 ºC. The reaction mixture was stirred at -20 ºC for 10 min and room temperature for 1.5 h before being filtered through Celite ® and concentrated in vacuo. The residue was purified by silica gel chromatography (toluene : diethyl ether = 3 : 1) to afford 7 (280 mg, 57%). 1 
Benzyl 3-O-benzyl-4,6-O-benzylidiene-2-O-[3,4,6-tri-O-acetyl-2-acetamido-2-deoxy-ß-Dglucopyranosyl]-α-D-mannopyranoside (8).
To an ethanol (50 mL) solution of 7 (900 mg, 1.04 mmol) was added hydrazine·hydrate (80% in water, 1.5 mL). The reaction mixture was heated at reflux for 4.5 h before being filtered and concentrated in vacuo. The residue was purified by silica gel chromatography (chloroform : methanol = 3 : 1) to afford the dephthaloyl product (500 mg, 95%). A mixture of the dephthaloyl product (500 mg, 0.82 mmol) and acetic anhydride (2.5 mL) in pyridine (5 mL) was stirred overnight at room temperature. The mixture was poured into ice water, and extracted with ethyl acetate. The organic layer was washed with water, dried over sodium sulfate, filtered, and concentrated in vacuo. The residue was purified by silica gel chromatography (chloroform : methanol = 3 : 1) to afford 8 (625 mg, 84%). 1 To a solution of 10 (136 mg, 0.20 mmol) and acetic anhydride (1.5 mL) was added hydrogen bromide (30% in acetic acid, 3 mL). The reaction mixture was stirred at room temperature for 4 h under a nitrogen atmosphere, and hydrogen bromide (30% in acetic acid, 3 mL) was added. The mixture was stirred overnight at room temperature, poured into ice water, and extracted with chloroform. 
2-(4-Iodophenyl)ethyl 2,3,4-tri-O-acetyl-6-O-(1-ethoxyethyl)-ß-D-glucopyranoside (18).
To a dichloromethane (10 mL 
2-[4-(Tributylstannyl)phenyl]ethyl 2,3,4-tri-O-acetyl-ß-D-glucopyranoside (19).
A mixture of 17 (310 mg, 0.40 mmol), pyridinium p-toluenesulfonate (10 mg, 0.040 mmol), and methanol (10 mL) was stirred at room temperature for 2 h. The solvent was removed, and the residue was purified by silica gel chromatography (hexane : ethyl acetate = 3 : 1 to 2 : 1) to afford 19 (268 mg, 95% 
2-(4-Iodophenyl)ethyl 2,3,4-tri-O-acetyl-ß-D-glucopyranoside (4).
To a methanol (10 mL To a solution of 4 (214 mg, 0.40 mmol), dichloromethane (10 mL), and toluene (10 mL) was added silver carbonate (121 mg, 0.44 mmol). The reaction mixture was stirred at room temperature for 1 h under a nitrogen atmosphere, and silver perchlorate (12 mg, 0.060 mmol) was added. After stirring for 20 min at room temperature, a solution of 3 (334 mg, 0.48 mmol), dichloromethane (10 mL), and toluene (10 mL) was added and the mixture was stirred for another 15 h. After the reaction was completed, the mixture was filtered. The filtrate was concentrated in vacuo, and the residue was purified by silica gel chromatography (hexane : ethyl acetate = 4 : 1 to ethyl acetate only) to afford 20 (310 mg, 67% 
2-[4-(Tributylstannyl)phenyl]ethyl 6-O-[2-O-(3,4,6-tri-O-acetyl-2-acetamido-2-deoxy-ß-Dglucopyranosyl)-3,4,6-tri-O-acetyl-α-D-mannopyranosyl]-2,3,4-tri-O-acetyl-ß-D-glucopyranoside (21).
To a solution of 19 (30 mg, 0.043 mmol), dichloromethane (1 mL), and toluene (1 mL) was added collidine (14 µL, 0.10 mmol). The reaction mixture was stirred at room temperature for 20 min under a nitrogen atmosphere, and silver perchlorate (11 mg, 0.052 mmol) was added. After stirring for 20 min at room temperature, a solution of 3 (36 mg, 0.052 mmol), dichloromethane (2 mL), and toluene (2 mL) was added and the mixture was stirred for another 5 h. After the reaction was completed, the mixture was filtered. To a methanol (10 mL) solution of 20 (188 mg, 0.16 mmol) was added sodium methoxide (28% in methanol, 332 µL, 1.63 mmol) and the mixture was stirred at room temperature for 2 h. After the reaction was completed, the mixture was neutralized with Amberlyst ® 15 (ca. 1.0 g) and filtered. The filtrate was concentrated in vacuo and the residue was purified by a recycle HPLC (LC-908, Japan
Analytical Industry Co. Ltd. Tokyo, Japan) on a reversed phase column (methanol : distilled water = 7 :
3) to afford 1 (74 mg, 59%). 1 
Benzyl 3-O-benzyl-2-O-[3,4,6-tri-O-acetyl-2-deoxy-2-phthalimido-ß-D-glucopyranosyl]-α-Dmannopyranoside (23).
A mixture of 7 (1.45 g, 1.67 mmol) and 70% acetic acid (10 mL) was stirred at 55 ºC for 2 h. The mixture was poured into ice water, neutralized with sodium hydrogencarbonate, and extracted with chloroform. The organic layer was washed with a saturated sodium hydrogencarbonate solution, dried over sodium sulfate, filtered, and concentrated in vacuo. The residue was purified by silica gel chromatography (chloroform : methanol = 20 : 1) to afford 23 (1.07 g, 83%). 1 
Benzyl 4-O-acetyl-3-O-benzyl-6-O-tert-butyldimethylsilyl-2-O-[3,4,6-tri-O-acetyl-2-deoxy-
2-phthalimido-ß-D-glucopyranosyl]-α-D-mannopyranoside (25).
A mixture of 24 (1.14 g, 1.28 mmol) and acetic anhydride (5 mL) in pyridine (5 mL) was stirred at room temperature for 2 h and methanol (20 mL) was added. The solvent was removed, and the residue was purified by silica gel chromatography (hexane : ethyl acetate = 2 : 1) to give 25 (1.18 g, 99%). 
O-benzyl-α-D-mannopyranoside (28).
To an ethanol (10 mL) solution of 27 (157 mg, 0.13 mmol) was added hydrazine·hydrate (80% in water, 200 µL). The reaction mixture was heated at reflux for 4 h before being concentrated in vacuo.
The residue was dissolved in pyridine (2 mL) and acetic anhydride (2 mL) was added. The mixture was stirred overnight at room temperature and methanol (20 mL) was added. The solvent was removed, and the residue was purified by silica gel chromatography (chloroform : methanol = 20 : 1) to give 28 (125 mg, 93%, 2 steps). 1 To an ethanol (10 mL) solution of 28 (118 mg, 0.11 mmol) was added Pd-C (10%, ca. 100 mg) and ammonium formate (140 mg). The reaction mixture was refluxed overnight, filtered through Celite ® and concentrated in vacuo. The residue was dissolved in pyridine (2 mL) and acetic anhydride (2 mL) was added. The mixture was stirred overnight at room temperature and methanol (20 mL) was added. The solvent was removed, and the residue was purified by silica gel chromatography (chloroform : methanol To a solution of 29 (70 mg, 0.073 mmol) and acetic anhydride (1.5 mL) was added hydrogen bromide (30% in acetic acid, 3 mL). The mixture was stirred overnight at room temperature, poured into ice water, and extracted with chloroform. sealed vial. The reaction was allowed to proceed at room temperature for 30 min. The reaction mixture was neutralized with sodium bicarbonate, and extracted with ethyl acetate. The extract was evaporated and methanol (100 µL) was added. To the solution was added sodium methoxide (28% in methanol, 1.6 µL). The reaction mixture was stirred at room temperature for 45 min, and neutralized with Amberlyst ® 15. The residue was purified by HPLC on a Cosmosil 5C18 AR-300 column (4.6×150 mm) with an isocratic solvent of H 2 O/acetonitrile (83/17) at a flow rate of 1.0 mL/min.
Enzymatic Reactions of Radioiodinated IPGMG.
GnT-V-transfected WiDr cells were used as the enzyme source. The protein concentration was measured by the Lowry method. 23 
GnT-V Activities in Rat Tissues.
Animal experiments were conducted in accordance with our institutional guidelines, and the experimental procedures were approved by the Kyoto University Animal Care Committee. Various tissues from male Wistar rats weighing 240-260 g were homogenized in 4 volumes of 10 mM Tris-HCl buffer (pH 7.4) containing 0.25 M sucrose. After centrifugation at 900 × g for 10 min, the supernatants were collected and used as crude enzyme preparations. The GnT-V activity and protein concentration were determined according to the procedures described above. 
